Mumbai: Eros Innovation, a global artificial intelligence and intellectual-property company, has announced the launch of Gujarat CARES 2025, a large-scale, AI-driven preventive healthcare initiative in partnership with the Centre for Cancer Epidemiology (CCE), Tata Memorial Centre (TMC), Mumbai. The programme will be powered by Eros GenAI, the company’s sovereign and ethical AI foundation-model platform.
Positioned as one of India’s most ambitious population-scale preventive health efforts, Gujarat CARES 2025 is a longitudinal, multi-year cohort study aimed at analysing genetic, lifestyle, environmental, behavioural, and digital health determinants across a wide spectrum of non-communicable diseases and wellness indicators.
The initiative will focus on key areas including cancer, diabetes and metabolic disorders, cardiovascular health, kidney and liver disease, women’s health, mental health, stress biomarkers, ageing, and longevity. Insights generated from the study will feed into Eros LifeScience’s AI Health Graph, enabling early-warning digital biomarkers, personalised preventive health scoring, longevity pathways, and public health dashboards at both state and national levels.
The study will be powered by Eros GenAI, trained on over 1.5 trillion tokens across structured lifestyle, behavioural, and cultural datasets. Purpose-built for health, wellness, and longevity analytics, the platform is designed to support India’s transition from treatment-led healthcare to prevention, early detection, and improved long-term outcomes.
Manju Lulla, Chairperson, Eros LifeScience said, “Every family deserves early warning, not late discovery. For decades, Eros has taken Indian stories and cinema to audiences across the world. With Eros LifeScience and Eros GenAI, we now want India to lead in something even more fundamental – keeping people healthier for longer.”
Dr. Rajesh Dixit, Director, Centre for Cancer Epidemiology (CCE), Tata Memorial Centre, said, “Gujarat CARES 2025 represents a major step forward in population-scale preventive health research. We are pleased to partner with Eros LifeScience and Eros GenAI, who are emerging as leaders in the application of ethical, large-scale AI to preventive healthcare. Their advanced AI platforms add a powerful new dimension to long-term epidemiological research, enabling high-quality, actionable insights for early detection, risk stratification, and prevention strategies that can meaningfully shape public health policy in India.”
Dr. Pankaj Chaturvedi, Director, ACTREC, said, “Tata Memorial Centre, ACTREC, and the Centre for Cancer Epidemiology are happy to work with Eros LifeScience to enable the Gujarat CARES 2025 study. The study employs a longitudinal methodology to investigate genetic, lifestyle, and environmental risk factors, integrating scientific rigor with robust community engagement. As an expansion of the Indian Study of Healthy Ageing (ISHA), this research is being conducted by the Molecular Epidemiology and Population Genomics divisions of CCE across Barshi, Varanasi, and Goa. The objective is to generate high-quality evidence that will support early detection strategies, personalized risk assessment, and the formulation of informed national health policies.”
Dr. Shilpa Desai, CEO, Eros HealthScience and R&D said, “Eros LifeScience is building one of the world’s most advanced AI-powered prevention engines. Gujarat CARES will generate real-world scientific evidence to detect risks early and save lives.”
The initiative is expected to establish the foundation for India’s first AI-powered public health prevention system, aligned with national priorities and built on sovereign, ethical AI principles. Insights from Gujarat CARES 2025 are also expected to inform scalable global prevention models for India, Asia, and other emerging markets.
Eros LifeScience, India’s first AI-driven preventive health and longevity platform, integrates lifestyle, lab, and where applicable, genomic insights to deliver personalised health dashboards, early-risk detection, wellness guidance, and government-ready population health intelligence—underscoring Eros Innovation’s broader mission to shift healthcare systems from treatment to prevention.
